XML 43 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Reverse Recapitalization (Tables)
6 Months Ended
Jun. 30, 2022
Reverse Recapitalization [Abstract]  
Summary of Business Acquisition Elements Reconciled To Consolidated Financial Statements The following table reconciles the elements of the Business Combination to the condensed consolidated statements of cash flows and the condensed consolidated statements of stockholders’ equity for the six months ended June 30, 2022 (in thousands):

 

Cash - CCAC’s trust and cash (net of redemption)

 

$

13,414

 

Cash - PIPE

 

 

36,950

 

Less: transaction costs and advisory fees paid

 

 

(6,609

)

Net cash from Business Combination and PIPE Financing

 

 

43,755

 

Less non-cash net liabilities assumed from CCAC

 

 

(15,955

)

Net contributions from Business Combination and PIPE Financing

 

$

27,800

 

Summary of Number of Shares of Common Stock Issued Immediately Following The Consummation of The Business Combination

The number of shares of common stock issued immediately following the consummation of the Business Combination were:

 

CCAC Class A Ordinary Shares, outstanding prior to Business Combination

 

 

27,600,000

 

CCAC Class B Ordinary Shares, outstanding prior to Business Combination

 

 

6,900,000

 

Less: redemption of CCAC Class A Ordinary Shares

 

 

(26,267,796

)

Shares issued from PIPE Financing

 

 

3,695,000

 

Total Shares from Business Combination and PIPE Financing

 

 

11,927,204

 

Legacy Quanergy shares(1)

 

 

71,485,143

 

Total shares of common stock immediately after Business Combination

 

 

83,412,347

 

 

Summary of Number of Legacy Quanergy Shares The number of Legacy Quanergy shares was determined as follows:

 

 

Quanergy
shares

 

Quanergy
shares,
effected for
Exchange
Ratio

Balance at December 31, 2020

 

4,696,352

 

18,221,534

Recapitalization applied to Convertible Preferred Stock outstanding at December 31, 2020

 

7,695,112

 

37,548,022

Shares issued upon exercise of options - 2021

 

20,000

 

77,595

Shares issued upon exercise of common stock warrants - 2021

 

2,324

 

9,016

Issuance of restricted stock awards

 

300,000

 

1,163,984

Conversion of 2023 Notes(2)

 

3,728,147

 

14,464,992

Total

 

 

 

71,485,143